Trial intelligence / Profile preview

Tapentadol effects on endogenous pain modulation in diabetic neuropathic pain and healthy volunteers

NL-OMON20737Active, not recruiting

Sponsor
Leiden University Medical Center
Start
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

Trial of tapentadol, morphine and Placebo-COD Research Private Ltd in Neuralgia (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Pain modulation, Diffuse noxious inhibitory control and 1 more. Started Jul 2011; status: active, not recruiting.

02

Drugs

tapentadolmorphinePlacebo-COD Research Private Ltd
03

Conditions

Neuralgia

Beyond the preview

Go deeper on NL-OMON20737.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20737.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call